10x Genomics, Inc. Operating Lease Liability
10x Genomics, Inc. (TXG) had Operating Lease Liability of $78.80 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-07
- 2026-06-30: Operating Lease, Liability $78.80M.
- 2026-03-31: Operating Lease, Liability $81.39M.
- 2025-12-31: Operating Lease, Liability $84.36M.
- 2025-09-30: Operating Lease, Liability $86.98M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $78.80M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $81.39M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $84.36M 10-K · filed 2026-02-13 |
| 2025-09-30 | $86.98M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $86.74M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $80.07M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $82.61M 10-K · filed 2025-02-13 |
| 2024-09-30 | $85.88M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $89.48M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $92.18M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $95.37M 10-K · filed 2024-02-15 |
| 2023-09-30 | $98.47M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $99.62M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $102.04M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $95.18M 10-K · filed 2023-02-16 |
| 2022-09-30 | $96.23M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $99.02M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $101.17M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $81.98M 10-K · filed 2022-02-18 |
| 2021-09-30 | $80.20M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $70.82M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $72.50M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $62.98M 10-K · filed 2021-02-26 |
| 2020-09-30 | $61.50M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $59.17M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $59.62M 10-Q · filed 2020-05-12 |
| 2020-01-01 | $53.80M 10-Q · filed 2020-11-12 |